It was shown that YKL-40 enhanced the upregulation of pro-inflammatory factors such as CCL2, IL-6, and IL-8, forming a positive feedback loop in the neuroinflammatory cascade, thereby accelerating the onset and progression of AD. This evidence concerns the gene CCL2 and Alzheimer disease.